Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Switching to statins: a challenge for primary care.

N G Fisher1, A J Marshall, J Went

  • 1South West Cardiothoracic Centre, Derriford Hospital, Plymouth, Devon, UK. Nick.fisher2@virgin.net

Journal of the Royal Society of Medicine
|February 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.

Cell death & disease·2014
Same author

Follicular dendritic cell secreted protein FDC-SP controls IgA production.

Mucosal immunology·2014
Same author

Haemoglobin levels in blood donors.

Glasgow medical journal·2010
Same author

Atenolol-Once-daily Dosage.

Proceedings of the Royal Society of Medicine·2010
Same author

Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice.

Journal of biomedical materials research. Part A·2010
Same author

Evaluating orangutan census techniques using nest decay rates: implications for population estimates.

Ecological applications : a publication of the Ecological Society of America·2008

New guidelines for statins (3-hydroxy-3-methylglutaryl coenzyme A inhibitors) were not widely adopted by patients previously treated for coronary heart disease (CHD). Many patients did not receive appropriate statin therapy, hindering prompt benefit from treatment advances.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Official guidelines for statin use in coronary heart disease (CHD) prevention were issued in England in 1997.
  • A study assessed patient adherence to these new guidelines six months post-issuance.

Purpose of the Study:

  • To evaluate the adoption of new statin guidelines by patients previously managed by a specialist lipid clinic.
  • To identify gaps in statin therapy for primary and secondary CHD prevention.

Main Methods:

  • A questionnaire survey was sent to 195 patients discharged from a lipid clinic in 1989, with general practitioner consent.
  • Analysis focused on 86 patients with current cholesterol measurements, examining their medication and morbidity over the subsequent decade.

Related Experiment Videos

Main Results:

  • Of 61 patients receiving primary CHD prevention, only 14 were on statins, and none met the new guideline criteria.
  • Of 25 patients receiving secondary CHD prevention, all qualified for statins, but only 14 were prescribed them, with 6 not achieving target cholesterol levels.

Conclusions:

  • Statin treatment was not consistently updated to align with new guidelines, potentially delaying patient benefit.
  • A coordinated approach to managing CHD risk factors, possibly via a central registry, is recommended for improved patient outcomes.